Nureca [NURECA] vs Fischer Medical [FISCHER] Detailed Stock Comparison
Nureca
NSE
Loading...
Fischer Medical
BSE
Loading...
TLDR: Quick Comparison Summary
Based on 19 vital metrics comparison: Nureca wins in 10 metrics, Fischer Medical wins in 7 metrics, with 0 ties. Nureca appears stronger overall.
View Metrics Details
Vital Metrics Comparison
| Metric | Nureca | Fischer Medical | Better |
|---|---|---|---|
| P/E Ratio (TTM) | 306.06 | 5,078.95 | Nureca |
| Price-to-Book Ratio | 1.21 | 31.88 | Nureca |
| Debt-to-Equity Ratio | 2.56 | 25.27 | Nureca |
| PEG Ratio | -2.08 | N/A | N/A |
| EV/EBITDA | -16.55 | 2,763.54 | Nureca |
| Profit Margin (TTM) | 0.00% | 1.31% | Fischer Medical |
| Operating Margin (TTM) | -3.20% | 4.05% | Fischer Medical |
| EBITDA Margin (TTM) | N/A | 4.05% | N/A |
| Return on Equity | 0.44% | 0.57% | Fischer Medical |
| Return on Assets (TTM) | 0.40% | 0.73% | Fischer Medical |
| Free Cash Flow (TTM) | $-234.06M | $-922.39M | Nureca |
| 1-Year Return | -11.46% | 51.77% | Fischer Medical |
| Price-to-Sales Ratio (TTM) | 1.91 | 55.78 | Nureca |
| Enterprise Value | $1.17B | $105.95B | Fischer Medical |
| EV/Revenue Ratio | 0.94 | 94.44 | Nureca |
| Gross Profit Margin (TTM) | 35.11% | 20.06% | Nureca |
| Revenue per Share (TTM) | $123 | $17 | Nureca |
| Earnings per Share (Diluted) | $0.85 | $0.19 | Nureca |
| Beta (Stock Volatility) | 0.49 | -0.02 | Fischer Medical |
Performance
Key Stats
Valuation
Financials
Short Interest
Dividends
Nureca vs Fischer Medical Stock Performance Analysis
Loading Price Chart...
Performance Comparison
Short-term Returns
| Stock | 1D | 1W | 1M | 3M | 6M | YTD |
|---|---|---|---|---|---|---|
| Nureca | -1.61% | -1.51% | -19.16% | -6.04% | -14.01% | -18.31% |
| Fischer Medical | 4.56% | 2.44% | 23.37% | 17.22% | 40.73% | 41.74% |
Long-term Returns
| Stock | 1Y | 3Y | 5Y | 10Y | 15Y | 20Y |
|---|---|---|---|---|---|---|
| Nureca | -11.46% | -76.93% | -65.74% | -65.74% | -65.74% | -65.74% |
| Fischer Medical | 51.77% | 1,996.22% | 2,217.52% | 1,368.90% | 10,998.33% | 11,302.40% |
Performance & Financial Health Analysis: Nureca vs Fischer Medical
| Metric | NURECA | FISCHER |
|---|---|---|
| Market Information | ||
| Market Cap | ₹2.36B | ₹62.58B |
| Market Cap Category | Small cap | Mid cap |
| 10 Day Avg. Volume | 13,778 | 2,481 |
| 90 Day Avg. Volume | 19,382 | 12,470 |
| Last Close | ₹232.25 | ₹998.85 |
| 52 Week Range | ₹203.62 - ₹447.50 | ₹573.60 - ₹1,020.80 |
| % from 52W High | -48.10% | -2.15% |
| All-Time High | ₹2,315.00 (Oct 04, 2021) | ₹2,386.00 (Apr 21, 2008) |
| % from All-Time High | -89.97% | -58.14% |
| Growth Metrics | ||
| Quarterly Revenue Growth | 0.69% | 1.37% |
| Quarterly Earnings Growth | -0.51% | -0.35% |
| Financial Health | ||
| Profit Margin (TTM) | 0.00% | 0.01% |
| Operating Margin (TTM) | -0.03% | 0.04% |
| Return on Equity (TTM) | 0.00% | 0.01% |
| Debt to Equity (MRQ) | 2.56 | 25.27 |
| Cash & Liquidity | ||
| Book Value per Share (MRQ) | ₹194.28 | ₹30.27 |
| Cash per Share (MRQ) | ₹123.05 | ₹22.54 |
| Operating Cash Flow (TTM) | ₹-172,050,000 | ₹-862,518,016 |
| Levered Free Cash Flow (TTM) | ₹8.46M | ₹-547,108,480 |
| Dividends | ||
| Last 12-Month Dividend Yield | N/A | N/A |
| Last 12-Month Dividend | ₹0.00 | N/A |
Valuation & Enterprise Metrics Analysis: Nureca vs Fischer Medical
| Metric | NURECA | FISCHER |
|---|---|---|
| Price Ratios | ||
| P/E Ratio (TTM) | 306.06 | 5,078.95 |
| Forward P/E | N/A | N/A |
| PEG Ratio | -2.08 | N/A |
| Price to Sales (TTM) | 1.91 | 55.78 |
| Price to Book (MRQ) | 1.21 | 31.88 |
| Market Capitalization | ||
| Market Capitalization | ₹2.36B | ₹62.58B |
| Enterprise Value | ₹1.17B | ₹105.95B |
| Enterprise Value Metrics | ||
| Enterprise to Revenue | 0.94 | 94.44 |
| Enterprise to EBITDA | -16.55 | 2,763.54 |
| Risk & Other Metrics | ||
| Beta | 0.49 | -0.02 |
| Book Value per Share (MRQ) | ₹194.28 | ₹30.27 |
Financial Statements Comparison: Nureca vs Fischer Medical
Financial Metrics
Loading Financial Charts...
Revenue
EBITDA
Operating Margin
Free Cash Flow
Long Term Debt
Profit Margin
Current Ratio
Operating Cash Flow
Income Statement (MRQ)
| Metric (MRQ) | NURECA | FISCHER |
|---|---|---|
| Revenue/Sales | ₹341.76M | ₹491.74M |
| Cost of Goods Sold | ₹221.78M | ₹393.11M |
| Gross Profit | ₹119.98M | ₹98.64M |
| Research & Development | N/A | N/A |
| Operating Income (EBIT) | ₹-10.93M | ₹19.93M |
| EBITDA | ₹20.11M | ₹25.49M |
| Pre-Tax Income | ₹12.31M | ₹18.12M |
| Income Tax | ₹4.18M | ₹5.00M |
| Net Income (Profit) | ₹8.13M | ₹13.12M |
Balance Sheet & Liquidity Metrics (MRQ)
| Metric (MRQ) | NURECA | FISCHER |
|---|---|---|
| Cash & Equivalents | ₹32.41M | ₹1.04B |
| Total Current Assets | ₹1.90B | ₹3.65B |
| Total Current Liabilities | ₹123.99M | ₹815.68M |
| Long-Term Debt | ₹25.90M | ₹374.59M |
| Total Shareholders Equity | ₹1.94B | ₹3.38B |
| Retained Earnings | ₹868.20M | N/A |
| Property, Plant & Equipment | ₹70.13M | ₹186.04M |
Cash Flow Statement Comparison (MRQ)
| Metric (MRQ) | NURECA | FISCHER |
|---|---|---|
| Operating Cash Flow | N/A | N/A |
| Capital Expenditures | N/A | N/A |
| Free Cash Flow | N/A | N/A |
| Debt Repayment | N/A | N/A |
| Common Stock Repurchase | N/A | N/A |
Short Interest & Institutional Ownership Analysis
| Metric | NURECA | FISCHER |
|---|---|---|
| Shares Short | N/A | N/A |
| Short Ratio | N/A | N/A |
| Short % of Float | N/A | N/A |
| Average Daily Volume (10 Day) | 13,778 | 2,481 |
| Average Daily Volume (90 Day) | 19,382 | 12,470 |
| Shares Outstanding | 10.00M | 63.80M |
| Float Shares | 3.39M | 25.71M |
| % Held by Insiders | 0.66% | 0.79% |
| % Held by Institutions | 0.00% | 0.03% |
Dividend Analysis & Yield Comparison: Nureca vs Fischer Medical
| Metric | NURECA | FISCHER |
|---|---|---|
| Last 12-Month Dividend | ₹0.00 | N/A |
| Last 12-Month Dividend Yield | N/A | N/A |
| 3-Year Avg Annual Dividend | ₹0.00 | N/A |
| 3-Year Avg Dividend Yield | N/A | N/A |
| 3-Year Total Dividends | ₹0.00 | N/A |
| Ex-Dividend Date | N/A | N/A |